...
首页> 外文期刊>Kidney international. >Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis
【24h】

Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis

机译:日本儿童特发性低分子量蛋白尿,高钙尿症和肾钙化病的CLCN5突变

获取原文

摘要

Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. The annual urinary screening of Japanese children above three years of age has identified a progressive renal tubular disorder characterized by low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. The disorder has been observed in over 60 patients and has a familial predisposition. Mutations of a renal chloride channel gene, CLCN5, have been reported in four such families, and we have undertaken studies in additional patients from 10 unrelated, non-consanguineous Japanese families to further characterize such CLCN5 mutations and to ascertain their prevalence. CLCN5 abnormalities were identified in 7 of the 10 unrelated patients and consisted of 5 mutations (2 nonsense, 1 frameshift and 2 missense), 1 deletion and 1 silent polymorphism. A clustering of these mutations in CLCN5 exons 8 and 10 was observed. Over 80% of the CLCN5 mutations could be readily detected by single stranded conformational polymorphism (SSCP) analysis, thereby providing a useful mutation screening method. Our results, which indicate that over 70% of Japanese patients with this renal tubulopathy have CLCN5 mutations, will help in the genetic and clinical evaluation of children at risk from this disorder.
机译:日本儿童特发性低分子量蛋白尿,高钙尿症和肾钙化病的CLCN5突变。每年对三岁以上的日本儿童进行尿液筛查,发现了以低分子量蛋白尿,高钙尿和肾钙化为特征的进行性肾小管疾病。该疾病已在60多名患者中观察到,并具有家族性倾向。已经在四个这样的家族中报道了一个氯化肾通道基因CLCN5的突变,我们已经对来自10个无关,无血缘日本家庭的其他患者进行了研究,以进一步表征此类CLCN5突变并确定其患病率。在10例无关患者中,有7例发现了CLCN5异常,包括5个突变(2个无意义,1个移码和2个错义),1个缺失和1个沉默多态性。在CLCN5外显子8和10中观察到这些突变的聚类。单链构象多态性(SSCP)分析可轻松检测到超过80%的CLCN5突变,从而提供了一种有用的突变筛选方法。我们的结果表明,超过70%的患有这种肾小管病的日本患者具有CLCN5突变,这将有助于对罹患这种疾病风险的儿童进行基因和临床评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号